Stacy E.F. Melanson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Substance Abuse Detection | 15 | 2021 | 283 | 4.420 |
Why?
|
Immunoassay | 12 | 2024 | 750 | 2.970 |
Why?
|
Urinalysis | 8 | 2021 | 370 | 2.340 |
Why?
|
Chromatography, Liquid | 11 | 2021 | 977 | 2.300 |
Why?
|
Tandem Mass Spectrometry | 12 | 2020 | 1156 | 1.890 |
Why?
|
Phlebotomy | 6 | 2017 | 142 | 1.670 |
Why?
|
Drug Monitoring | 7 | 2021 | 961 | 1.620 |
Why?
|
Laboratories | 10 | 2021 | 458 | 1.510 |
Why?
|
Clinical Laboratory Information Systems | 4 | 2017 | 107 | 1.480 |
Why?
|
Cannabis | 2 | 2023 | 430 | 1.090 |
Why?
|
Chemistry, Clinical | 5 | 2024 | 64 | 1.070 |
Why?
|
Buprenorphine | 4 | 2019 | 634 | 0.980 |
Why?
|
Analgesics, Opioid | 11 | 2021 | 3650 | 0.970 |
Why?
|
Saliva | 2 | 2019 | 805 | 0.920 |
Why?
|
Efficiency, Organizational | 4 | 2017 | 694 | 0.810 |
Why?
|
Piracetam | 1 | 2021 | 87 | 0.790 |
Why?
|
Cannabinoids | 1 | 2023 | 167 | 0.750 |
Why?
|
Blood Specimen Collection | 4 | 2018 | 246 | 0.720 |
Why?
|
Workflow | 7 | 2021 | 831 | 0.710 |
Why?
|
Personnel Staffing and Scheduling | 2 | 2014 | 502 | 0.680 |
Why?
|
Clinical Laboratory Techniques | 3 | 2023 | 744 | 0.670 |
Why?
|
Cocaine-Related Disorders | 2 | 2020 | 459 | 0.670 |
Why?
|
Hallucinogens | 1 | 2021 | 180 | 0.660 |
Why?
|
Troponin I | 5 | 2015 | 616 | 0.640 |
Why?
|
Medication Adherence | 4 | 2017 | 2047 | 0.640 |
Why?
|
Academic Medical Centers | 5 | 2018 | 2749 | 0.570 |
Why?
|
Fentanyl | 3 | 2020 | 412 | 0.560 |
Why?
|
Patient Compliance | 3 | 2019 | 2679 | 0.550 |
Why?
|
Clonazepam | 1 | 2016 | 137 | 0.540 |
Why?
|
Myoglobin | 2 | 2006 | 160 | 0.530 |
Why?
|
Substance-Related Disorders | 5 | 2020 | 4239 | 0.510 |
Why?
|
Pain | 5 | 2014 | 4923 | 0.500 |
Why?
|
Coma | 1 | 2018 | 471 | 0.490 |
Why?
|
Hospital Information Systems | 1 | 2017 | 395 | 0.490 |
Why?
|
Electronic Health Records | 5 | 2018 | 4426 | 0.480 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2006 | 1557 | 0.470 |
Why?
|
Immunoenzyme Techniques | 3 | 2012 | 1801 | 0.470 |
Why?
|
Analgesics | 4 | 2021 | 1034 | 0.470 |
Why?
|
Vancomycin | 2 | 2013 | 500 | 0.450 |
Why?
|
Point-of-Care Systems | 5 | 2022 | 1175 | 0.440 |
Why?
|
Laboratories, Hospital | 4 | 2017 | 194 | 0.440 |
Why?
|
Glucuronidase | 1 | 2014 | 207 | 0.430 |
Why?
|
Benzodiazepines | 2 | 2018 | 1099 | 0.420 |
Why?
|
Creatine Kinase, MB Form | 2 | 2014 | 214 | 0.390 |
Why?
|
Pharmaceutical Preparations | 1 | 2019 | 1066 | 0.390 |
Why?
|
Sensitivity and Specificity | 12 | 2023 | 14740 | 0.380 |
Why?
|
False Positive Reactions | 5 | 2018 | 982 | 0.380 |
Why?
|
Legislation, Drug | 2 | 2023 | 206 | 0.370 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 2010 | 114 | 0.370 |
Why?
|
Patient Identification Systems | 1 | 2010 | 79 | 0.360 |
Why?
|
Narcotics | 1 | 2012 | 343 | 0.350 |
Why?
|
Peptide Fragments | 3 | 2006 | 5076 | 0.350 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 257 | 0.350 |
Why?
|
Humans | 84 | 2024 | 739398 | 0.340 |
Why?
|
Pain Measurement | 2 | 2018 | 3419 | 0.320 |
Why?
|
Opioid-Related Disorders | 2 | 2021 | 2059 | 0.320 |
Why?
|
Troponin T | 3 | 2011 | 748 | 0.320 |
Why?
|
Autoanalysis | 1 | 2007 | 72 | 0.310 |
Why?
|
Cost Savings | 1 | 2013 | 925 | 0.300 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2009 | 392 | 0.300 |
Why?
|
Enzyme Multiplied Immunoassay Technique | 1 | 2006 | 7 | 0.300 |
Why?
|
Promethazine | 1 | 2006 | 29 | 0.300 |
Why?
|
Medical Errors | 2 | 2018 | 1291 | 0.290 |
Why?
|
Benchmarking | 1 | 2013 | 1034 | 0.290 |
Why?
|
Fish Oils | 2 | 2005 | 469 | 0.290 |
Why?
|
Epilepsy | 1 | 2021 | 3289 | 0.270 |
Why?
|
Blood Gas Analysis | 1 | 2007 | 380 | 0.270 |
Why?
|
Amphetamine | 1 | 2006 | 225 | 0.260 |
Why?
|
Patient Satisfaction | 3 | 2017 | 3382 | 0.260 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2007 | 433 | 0.260 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2006 | 215 | 0.260 |
Why?
|
Troponin | 2 | 2014 | 516 | 0.260 |
Why?
|
Cyclophosphamide | 1 | 2010 | 2238 | 0.250 |
Why?
|
Donor Selection | 1 | 2006 | 201 | 0.250 |
Why?
|
Vaccines | 2 | 2024 | 802 | 0.250 |
Why?
|
Clinical Chemistry Tests | 1 | 2004 | 61 | 0.240 |
Why?
|
Diagnostic Tests, Routine | 2 | 2014 | 789 | 0.240 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2006 | 425 | 0.240 |
Why?
|
Health Planning Guidelines | 1 | 2005 | 163 | 0.240 |
Why?
|
Blood Donors | 1 | 2006 | 357 | 0.240 |
Why?
|
Drug Prescriptions | 3 | 2011 | 1637 | 0.230 |
Why?
|
Hydrocarbons, Chlorinated | 1 | 2005 | 126 | 0.230 |
Why?
|
Peroxidase | 1 | 2006 | 608 | 0.230 |
Why?
|
Ambulatory Care | 1 | 2014 | 2711 | 0.220 |
Why?
|
Colorado | 1 | 2023 | 163 | 0.220 |
Why?
|
Emergency Service, Hospital | 8 | 2023 | 7626 | 0.220 |
Why?
|
Medical History Taking | 1 | 2006 | 782 | 0.210 |
Why?
|
Running | 1 | 2006 | 476 | 0.210 |
Why?
|
Education, Medical | 1 | 2013 | 1712 | 0.200 |
Why?
|
Limit of Detection | 2 | 2020 | 264 | 0.200 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 2216 | 0.190 |
Why?
|
Automation, Laboratory | 1 | 2021 | 99 | 0.190 |
Why?
|
Outpatients | 3 | 2021 | 1469 | 0.190 |
Why?
|
Creatinine | 3 | 2022 | 1903 | 0.190 |
Why?
|
Laboratory Proficiency Testing | 1 | 2019 | 19 | 0.180 |
Why?
|
Blood Transfusion | 1 | 2006 | 1296 | 0.180 |
Why?
|
Antibodies, Viral | 4 | 2024 | 3151 | 0.180 |
Why?
|
Acute Coronary Syndrome | 2 | 2014 | 2331 | 0.170 |
Why?
|
Immunoglobulin A | 1 | 2023 | 989 | 0.170 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2020 | 1580 | 0.170 |
Why?
|
Boston | 5 | 2020 | 9314 | 0.170 |
Why?
|
Bicycling | 1 | 2020 | 174 | 0.170 |
Why?
|
Immunochemistry | 1 | 2018 | 125 | 0.160 |
Why?
|
Dyspnea | 1 | 2006 | 1295 | 0.160 |
Why?
|
Analgesia, Obstetrical | 1 | 2020 | 181 | 0.160 |
Why?
|
Central Nervous System Stimulants | 1 | 2006 | 1146 | 0.160 |
Why?
|
Immunoglobulin M | 1 | 2023 | 1537 | 0.160 |
Why?
|
Mercury | 2 | 2005 | 282 | 0.150 |
Why?
|
Analgesia, Epidural | 1 | 2020 | 329 | 0.150 |
Why?
|
Chest Pain | 1 | 2004 | 1112 | 0.150 |
Why?
|
Naloxone | 1 | 2019 | 367 | 0.140 |
Why?
|
Myocardial Infarction | 3 | 2015 | 11668 | 0.140 |
Why?
|
Attitude to Computers | 1 | 2017 | 202 | 0.140 |
Why?
|
Body Fluids | 1 | 2018 | 318 | 0.140 |
Why?
|
Quality Control | 1 | 2018 | 842 | 0.130 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2005 | 1338 | 0.130 |
Why?
|
Reproducibility of Results | 6 | 2016 | 19811 | 0.130 |
Why?
|
Genetic Variation | 1 | 2010 | 6539 | 0.130 |
Why?
|
Automobile Driving | 1 | 2020 | 431 | 0.130 |
Why?
|
Morphine | 2 | 2014 | 655 | 0.130 |
Why?
|
Pathology, Clinical | 1 | 2018 | 363 | 0.130 |
Why?
|
Narcotic Antagonists | 1 | 2019 | 562 | 0.120 |
Why?
|
Accidents, Traffic | 1 | 2020 | 817 | 0.120 |
Why?
|
Myocardium | 1 | 2007 | 4788 | 0.120 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4522 | 0.120 |
Why?
|
Pandemics | 3 | 2024 | 8274 | 0.120 |
Why?
|
Kidney Function Tests | 2 | 2008 | 681 | 0.120 |
Why?
|
Blood Glucose | 2 | 2022 | 6237 | 0.120 |
Why?
|
Refrigeration | 1 | 2013 | 28 | 0.120 |
Why?
|
Pulmonary Embolism | 1 | 2006 | 2365 | 0.120 |
Why?
|
Specimen Handling | 3 | 2019 | 692 | 0.120 |
Why?
|
Porphyrias | 1 | 2003 | 56 | 0.110 |
Why?
|
Documentation | 1 | 2019 | 861 | 0.110 |
Why?
|
Morphine Derivatives | 1 | 2013 | 44 | 0.110 |
Why?
|
Tumor Lysis Syndrome | 1 | 2013 | 42 | 0.110 |
Why?
|
Urate Oxidase | 1 | 2013 | 34 | 0.110 |
Why?
|
Calibration | 1 | 2016 | 818 | 0.110 |
Why?
|
Walking | 1 | 2020 | 1177 | 0.110 |
Why?
|
Tramadol | 1 | 2013 | 50 | 0.110 |
Why?
|
United States | 5 | 2023 | 69573 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5401 | 0.110 |
Why?
|
Forensic Toxicology | 1 | 2012 | 6 | 0.110 |
Why?
|
Urine | 1 | 2014 | 370 | 0.110 |
Why?
|
Coronary Disease | 1 | 2007 | 6068 | 0.110 |
Why?
|
Oligopeptides | 3 | 2004 | 1179 | 0.100 |
Why?
|
Dietary Supplements | 1 | 2005 | 3279 | 0.100 |
Why?
|
Time | 1 | 2013 | 528 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2021 | 1907 | 0.100 |
Why?
|
Models, Statistical | 1 | 2006 | 5113 | 0.100 |
Why?
|
Female | 17 | 2022 | 378853 | 0.100 |
Why?
|
Time Factors | 6 | 2017 | 40050 | 0.100 |
Why?
|
Physical Exertion | 2 | 2006 | 695 | 0.090 |
Why?
|
Myeloablative Agonists | 1 | 2010 | 218 | 0.090 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2010 | 65 | 0.090 |
Why?
|
Middle Aged | 14 | 2022 | 212863 | 0.090 |
Why?
|
Glucose | 1 | 2022 | 4377 | 0.090 |
Why?
|
Creatine Kinase | 3 | 2014 | 694 | 0.090 |
Why?
|
Education, Medical, Graduate | 2 | 2018 | 2275 | 0.090 |
Why?
|
Substance P | 2 | 2000 | 333 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1941 | 0.080 |
Why?
|
Oxycodone | 1 | 2010 | 150 | 0.080 |
Why?
|
Automation | 1 | 2011 | 584 | 0.080 |
Why?
|
Cocaine | 1 | 2013 | 1008 | 0.080 |
Why?
|
Glomerular Filtration Rate | 2 | 2022 | 2184 | 0.080 |
Why?
|
Uric Acid | 1 | 2013 | 753 | 0.070 |
Why?
|
Reference Values | 3 | 2014 | 4983 | 0.070 |
Why?
|
Adult | 10 | 2022 | 213394 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2020 | 76631 | 0.070 |
Why?
|
Male | 18 | 2022 | 349022 | 0.070 |
Why?
|
Ultrasonography | 2 | 1999 | 5941 | 0.070 |
Why?
|
Acute Disease | 2 | 2007 | 7128 | 0.070 |
Why?
|
Teratogens | 1 | 2006 | 113 | 0.070 |
Why?
|
Luminescent Measurements | 1 | 2007 | 405 | 0.060 |
Why?
|
Serum | 1 | 2006 | 211 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2011 | 2373 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2020 | 25470 | 0.060 |
Why?
|
Reference Standards | 2 | 2022 | 1018 | 0.060 |
Why?
|
Cross Reactions | 1 | 2006 | 840 | 0.060 |
Why?
|
Receptors, Tachykinin | 1 | 2004 | 25 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5272 | 0.060 |
Why?
|
Data Collection | 2 | 2011 | 3341 | 0.060 |
Why?
|
Nurses | 1 | 2013 | 2455 | 0.060 |
Why?
|
Pesticide Residues | 1 | 2005 | 94 | 0.060 |
Why?
|
Aged | 6 | 2021 | 162698 | 0.060 |
Why?
|
Inpatients | 2 | 2014 | 2478 | 0.060 |
Why?
|
Forms and Records Control | 1 | 2004 | 160 | 0.060 |
Why?
|
Cytokines | 1 | 2019 | 7298 | 0.060 |
Why?
|
Anti-Anxiety Agents | 1 | 2006 | 390 | 0.060 |
Why?
|
Fiber Optic Technology | 1 | 1995 | 287 | 0.060 |
Why?
|
Transplantation Conditioning | 1 | 2010 | 1593 | 0.060 |
Why?
|
Receptors, Opioid | 1 | 2004 | 155 | 0.060 |
Why?
|
Societies | 1 | 2024 | 105 | 0.060 |
Why?
|
CD40 Ligand | 1 | 2005 | 527 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3844 | 0.060 |
Why?
|
Liver Function Tests | 1 | 2004 | 527 | 0.050 |
Why?
|
Antibodies, Neutralizing | 2 | 2023 | 1957 | 0.050 |
Why?
|
Guidelines as Topic | 1 | 2009 | 1407 | 0.050 |
Why?
|
Polychlorinated Biphenyls | 1 | 2005 | 245 | 0.050 |
Why?
|
Albumins | 1 | 2005 | 563 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2008 | 15036 | 0.050 |
Why?
|
Internship and Residency | 2 | 2018 | 5761 | 0.050 |
Why?
|
Prospective Studies | 4 | 2023 | 53037 | 0.050 |
Why?
|
Probability | 1 | 2006 | 2500 | 0.050 |
Why?
|
ROC Curve | 2 | 2006 | 3526 | 0.050 |
Why?
|
Hospitals | 2 | 2022 | 3916 | 0.050 |
Why?
|
Capnography | 1 | 2001 | 89 | 0.050 |
Why?
|
Apgar Score | 1 | 2020 | 123 | 0.050 |
Why?
|
Blood Coagulation Tests | 1 | 2021 | 261 | 0.050 |
Why?
|
American Heart Association | 1 | 2005 | 1050 | 0.050 |
Why?
|
Alleles | 1 | 2010 | 6942 | 0.040 |
Why?
|
Commerce | 1 | 2005 | 590 | 0.040 |
Why?
|
Survival Analysis | 2 | 2010 | 10247 | 0.040 |
Why?
|
Isoenzymes | 1 | 2004 | 1720 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 631 | 0.040 |
Why?
|
Injections, Spinal | 2 | 2013 | 303 | 0.040 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2022 | 430 | 0.040 |
Why?
|
Hematologic Neoplasms | 1 | 2010 | 1800 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2009 | 2261 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2014 | 4365 | 0.040 |
Why?
|
Workload | 1 | 2004 | 843 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2005 | 1548 | 0.040 |
Why?
|
Blood Banks | 1 | 2018 | 110 | 0.040 |
Why?
|
Indoles | 2 | 2004 | 1832 | 0.040 |
Why?
|
Vitamin D | 1 | 2012 | 3197 | 0.040 |
Why?
|
Polymers | 1 | 1995 | 1616 | 0.040 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 454 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 38942 | 0.040 |
Why?
|
Maternal Age | 1 | 2020 | 803 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2716 | 0.040 |
Why?
|
Emergency Medical Technicians | 1 | 1997 | 116 | 0.030 |
Why?
|
Ischemia | 1 | 2005 | 1908 | 0.030 |
Why?
|
Genotype | 1 | 2010 | 12951 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2006 | 12948 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 2 | 2004 | 3770 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2021 | 1122 | 0.030 |
Why?
|
Stroke Volume | 1 | 2008 | 4941 | 0.030 |
Why?
|
Trauma Centers | 1 | 2020 | 888 | 0.030 |
Why?
|
Risk | 1 | 2006 | 9684 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2006 | 2836 | 0.030 |
Why?
|
Logistic Models | 2 | 2006 | 13402 | 0.030 |
Why?
|
Chronic Disease | 1 | 2009 | 9133 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 7136 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2007 | 3672 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2006 | 3066 | 0.030 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2001 | 967 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2019 | 1199 | 0.030 |
Why?
|
History, 18th Century | 1 | 2003 | 214 | 0.030 |
Why?
|
Temperature | 1 | 2019 | 2202 | 0.030 |
Why?
|
Self Report | 1 | 2023 | 3524 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2019 | 1883 | 0.030 |
Why?
|
Algorithms | 1 | 2012 | 13872 | 0.030 |
Why?
|
HIV | 1 | 1999 | 1607 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 7274 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2013 | 441 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2015 | 57650 | 0.020 |
Why?
|
Heart Arrest | 1 | 2001 | 1458 | 0.020 |
Why?
|
Drug Tolerance | 2 | 2004 | 376 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3232 | 0.020 |
Why?
|
Fishes | 1 | 2003 | 563 | 0.020 |
Why?
|
History, 19th Century | 1 | 2003 | 721 | 0.020 |
Why?
|
Seafood | 1 | 2003 | 379 | 0.020 |
Why?
|
RNA, Viral | 1 | 1999 | 2907 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3193 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 12985 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 9259 | 0.020 |
Why?
|
Emergency Medicine | 1 | 1999 | 1201 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1253 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2014 | 1675 | 0.020 |
Why?
|
Echocardiography | 1 | 2001 | 5098 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2012 | 1166 | 0.020 |
Why?
|
Pennsylvania | 2 | 1999 | 615 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 3 | 2004 | 8299 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 1997 | 2146 | 0.020 |
Why?
|
Artifacts | 1 | 2014 | 1905 | 0.020 |
Why?
|
Curriculum | 1 | 2018 | 3575 | 0.020 |
Why?
|
History, 20th Century | 1 | 2003 | 2742 | 0.020 |
Why?
|
Internationality | 1 | 2011 | 1004 | 0.020 |
Why?
|
Prognosis | 1 | 2005 | 28901 | 0.020 |
Why?
|
Diet | 1 | 2022 | 7876 | 0.010 |
Why?
|
Electrocardiography | 1 | 1997 | 6426 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15153 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1995 | 956 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2006 | 20055 | 0.010 |
Why?
|
Receptors, Opioid, mu | 1 | 2004 | 179 | 0.010 |
Why?
|
Exercise | 1 | 1999 | 5591 | 0.010 |
Why?
|
Formaldehyde | 1 | 2004 | 354 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2007 | 15070 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10208 | 0.010 |
Why?
|
Rats | 3 | 2004 | 24270 | 0.010 |
Why?
|
Isoindoles | 1 | 2000 | 41 | 0.010 |
Why?
|
Linear Models | 1 | 2011 | 5948 | 0.010 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2000 | 128 | 0.010 |
Why?
|
Pain Threshold | 1 | 2004 | 583 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 56255 | 0.010 |
Why?
|
Methylhistidines | 1 | 1999 | 37 | 0.010 |
Why?
|
Light | 1 | 1995 | 1380 | 0.010 |
Why?
|
Patients' Rooms | 1 | 1999 | 63 | 0.010 |
Why?
|
Naltrexone | 1 | 2000 | 305 | 0.010 |
Why?
|
Catheterization | 1 | 2004 | 1466 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29002 | 0.010 |
Why?
|
Reaction Time | 1 | 2004 | 2097 | 0.010 |
Why?
|
Utilization Review | 1 | 1999 | 392 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2004 | 1891 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2001 | 2881 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1999 | 1581 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2000 | 3146 | 0.010 |
Why?
|
Drug Design | 1 | 2000 | 1088 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2001 | 3510 | 0.010 |
Why?
|
Animals | 4 | 2004 | 168368 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 71974 | 0.010 |
Why?
|
Abdomen | 1 | 1999 | 1104 | 0.010 |
Why?
|
HIV Infections | 1 | 1999 | 16764 | 0.010 |
Why?
|
Virus Replication | 1 | 1999 | 2529 | 0.010 |
Why?
|
Program Evaluation | 1 | 1999 | 2484 | 0.010 |
Why?
|
Neutrophils | 1 | 1999 | 3698 | 0.000 |
Why?
|
Emergency Medical Services | 1 | 1997 | 1904 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1997 | 11985 | 0.000 |
Why?
|
Clinical Competence | 1 | 1997 | 4671 | 0.000 |
Why?
|